BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1613997)

  • 1. [Antiplatelet therapy in cardiac diseases].
    Aosaki M; Iwade K; Kimata S; Hosoda S
    Nihon Rinsho; 1992 Feb; 50(2):397-402. PubMed ID: 1613997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
    Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
    Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet drugs in cardiovascular prevention: coronary events: acute phase and secondary prevention.
    Prescrire Int; 2000 Jun; 9(47):83-5. PubMed ID: 11010749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A feasibility study of the safety and efficacy of a combined clopidogrel and aspirin regimen following off-pump coronary artery bypass grafting.
    Shennib H; Endo M; Benhameid O
    Heart Surg Forum; 2003; 6(5):288-91. PubMed ID: 14721795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-platelet drugs (aspirin, ticlopidine, etc)].
    Ikeda U
    Nihon Rinsho; 2006 Apr; 64(4):743-7. PubMed ID: 16613193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Low-dose aspirin in the long-term treatment of the patient with ischemic heart disease].
    Magnani B; Semprini F
    Cardiologia; 1994 Dec; 39(12 Suppl 1):15-21. PubMed ID: 7634259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Platelet antiaggregants in the treatment of arterial thrombosis].
    Ferlito S
    Minerva Cardioangiol; 1991 Oct; 39(10):375-89. PubMed ID: 1803283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of antiplatelet effects of a modified protocol by platelet aggregation in patients undergoing "one-stop" hybrid coronary revascularization.
    Gao P; Xiong H; Zheng Z; Li L; Gao R; Hu SS
    Platelets; 2010; 21(3):183-90. PubMed ID: 20201634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute coronary syndrome -- long term protection by dual thrombocyte aggregation inhibition during twelve months].
    MMW Fortschr Med; 2008 Oct; 150(42):52-3. PubMed ID: 18983063
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preventive drug therapy following coronary bypass surgery or PTCA].
    Lechleitner P; Genser N; Dienstl F
    Wien Med Wochenschr; 1990 Jun; 140(10-11):277-8, 281. PubMed ID: 2368420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of platelet inhibition of ticlopidine plus aspirin vs aspirin alone given prior to elective PTCA.
    van de Loo A; Nauck M; Noory E; Just H; Wollschläger H
    Eur Heart J; 1998 Jan; 19(1):96-102. PubMed ID: 9503181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.
    ; Mehta SR; Bassand JP; Chrolavicius S; Diaz R; Eikelboom JW; Fox KA; Granger CB; Jolly S; Joyner CD; Rupprecht HJ; Widimsky P; Afzal R; Pogue J; Yusuf S
    N Engl J Med; 2010 Sep; 363(10):930-42. PubMed ID: 20818903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balancing the benefit and risk of oral antiplatelet agents in coronary artery bypass surgery.
    Cannon CP; Mehta SR; Aranki SF
    Ann Thorac Surg; 2005 Aug; 80(2):768-79. PubMed ID: 16039260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
    Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E
    J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet therapy--Part I.
    Goodnight SH; Coull BM; McAnulty JH; Taylor LM
    West J Med; 1993 Apr; 158(4):385-92. PubMed ID: 8317125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy.
    Solheim S; Seljeflot I; Lunde K; Bjørnerheim R; Aakhus S; Forfang K; Arnesen H
    Am J Cardiol; 2010 Nov; 106(9):1197-200. PubMed ID: 21029812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined carotid stenting and urgent coronary artery surgery in unstable angina patients with severe carotid stenosis.
    Guerra M; Mota JC; Veloso M; Gama V; Vouga L
    Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):278-81. PubMed ID: 19416961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intracoronary dipyridamole reduces the incidence of acute coronary vessel occlusion in percutaneous transluminal coronary angioplasty--a prospective randomized study].
    Heintzen MP; Heidland UE; Klimek WJ; Michel CJ; Kelm M; Leschke M; Schwartzkopff B; Vester EG; Strauer BE
    Z Kardiol; 1997 Dec; 86(12):961-7. PubMed ID: 9499493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.